KIT and neoplasm: Gain-of-function mutations in the growth factor receptor genes for KIT (CD117) and platelet-derived growth factor α (PDGFRA) drive tumor development in 85–90% of GISTs to promote constitutive activation of growth factor signaling pathways that cause uncontrolled cell proliferation.